expression and purification of truncated diphtheria toxin, dt386, in escherichia coli: an attempt for production of a new vaccine against diphtheria
نویسندگان
چکیده
the aim of this study was to produce a recombinant protein consisting of the catalytic and translocation domains of diphtheria toxin for its later application as a vaccine candidate against corynebacterium diphtheria. to achieve this goal, at first, the amino acid sequence of dt386 was used for prediction of t and b cell epitopes using on-line servers. the dt386 coding sequence was synthesized and subcloned into the ncoi and xhoi sites of pet28a plasmid and recombinant pet28a plasmid was used to transform escherichia coli bl21 (de3) host cells. afterwards, recombinant cells were selected and subjected to induction of expression by 1 mm isopropyl β-d-1-thiogalactopyranoside, (iptg). expression of the desired protein was evaluated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (sds-page) and western blotting, and finally, the recombinant protein was purified using nickel affinity chromatography. the results of epitope prediction using on-line servers established the ability of dt386 for stimulation of immune system against diphtheria toxin. restriction digestion of the recombinant plasmids using ncoi and xhoi enzymes confirmed the fidelity of cloning by producing a band of about 1200 bp. sds-page analysis following induction of expression and also purification step confirmed the expression of the desired protein by showing a band of about 45 kda. in addition, western blot analysis using anti-6x-his antibody confirmed the identity of the expected protein. in conclusion, in the present study we amplified and cloned the coding sequence of dt386 fragment, followed by its expression by e. coli bl21 (de3) cells. then, the expressed protein was purified and will be used for later studies of evaluation of its immunogenic properties.
منابع مشابه
Expression and purification of truncated diphtheria toxin, DT386, in Escherichia coli: An attempt for production of a new vaccine against diphtheria
The aim of this study was to produce a recombinant protein consisting of the catalytic and translocation domains of diphtheria toxin for its later application as a vaccine candidate against Corynebacterium diphtheria. To achieve this goal, at first, the amino acid sequence of DT386 was used for prediction of T and B cell epitopes using on-line servers. The DT386 coding sequence was synthesized ...
متن کاملproduction and purification of polyclonal antibodies against diphtheria toxin
diphtheria is a fatal disease caused by exotoxin of corynebacterium diphtheria . this toxin consists of two chains, catalytic chain (a) and binding (b) chain. by binding chain (b), the toxin binds to its receptor on numerous body cells such as myocardial, kidney and peripheral nerve cells. after entering, catalytic chain (a) inhibits protein synthesis and finally can cause cell dea...
متن کاملTowards a recombinant vaccine against diphtheria toxin.
Two recombinant fragments of diphtheria toxin (DT) were fused to an engineered tandem repeat of the immunoglobulin (Ig) binding domain of protein A, called ZZ. These fragments are (i) the receptor binding domain (DTR), which comprises amino acids 382 to 535 of DT, and (ii) a linear peptide (DT(168-220)) which comprises residues 168 to 220 of the loop between fragment A and fragment B of DT. The...
متن کاملThe Production of Diphtheria Toxin
Toxin of sufficient strength to kill a 400-gramme guinea-pig in three days and a half in a dose of 0.cubic centimetre developed in suitable bouillon, contained in ordinary Erlenmeyer flasks, within a period of twenty-four hours. In such boullon the toxin reached its greatest strength in from four to seven days (0.005 cubic centimetre killing a 500-gramme guinea-pig in three days). This period o...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
research in pharmaceutical sciencesجلد ۱۱، شماره ۵، صفحات ۴۲۸-۰
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023